Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer
- Conditions
- Cancer
- Interventions
- Other: Family History InformationGenetic: ORAGENEGenetic: BloodOther: Skin Biopsy
- Registration Number
- NCT03922893
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Brief Summary
This study is being done to attempt to identify genetic mutations or other gene-based variations in adults and children who have cancer, or are likely to develop an inherited form of cancer, and potentially reduce their risk for cancer or treat the cancer earlier.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1500
- Individuals who have undergone clinical and/or research genetic evaluation, found to have or not have a germline genetic variant (pathogenic, likely pathogenic, variant of uncertain/unknown significance, likely benign).
- Individuals with or without a personal history of malignant or pre-malignant lesions who demonstrate: a) clinical findings suggestive of a genetic cancer susceptibility syndrome including very early age at onset, multiple primary malignancies, or other features; and/or b) family histories suggestive of a genetic cancer susceptibility syndrome, or c) other features suggesting inherited etiology of malignancy as determined by the PI.
- Family members of the above participants. Both children (with parental consent as age appropriate) and adults are eligible to participation.
- Individuals may or may not be enrolled MSK patients; probands may be referred to (or self-referred to) the study and may be enrolled at discretion of the PI and if able to provide informed consent.
- Biospecimens derived from deceased family members may be used for research in this study if consent if provided by the executor of the estate of that individual.
- Patients will be excluded from this study if he/she has physical, cognitive or psychiatric conditions that interfere with ability to give meaningful informed consent.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Proband Blood First individual in a family to consent to this protocol Family Member Participants Blood Family members of the proband will be approached to consent to this protocol Family Member Participants Skin Biopsy Family members of the proband will be approached to consent to this protocol Proband ORAGENE First individual in a family to consent to this protocol Proband Skin Biopsy First individual in a family to consent to this protocol Family Member Participants Family History Information Family members of the proband will be approached to consent to this protocol Family Member Participants ORAGENE Family members of the proband will be approached to consent to this protocol Proband Family History Information First individual in a family to consent to this protocol
- Primary Outcome Measures
Name Time Method Discovery of novel cancer susceptibility genes Up to 10 years
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (7)
Memorial Sloan Kettering Monmouth (Consent only)
🇺🇸Middletown, New Jersey, United States
Memorial Sloan Kettering Basking Ridge (Consent only)
🇺🇸Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Bergen (Consent only )
🇺🇸Montvale, New Jersey, United States
Memorial Sloan Kettering Cancer Center @ Commack (Consent Only)
🇺🇸Commack, New York, United States
Memorial Sloan Kettering Cancer Center
🇺🇸New York, New York, United States
Memorial Sloan Kettering Westchester (Consent only)
🇺🇸Harrison, New York, United States
Memorial Sloan Kettering Nassau (Consent only)
🇺🇸Uniondale, New York, United States